EUVIMEDEUVIMED entdecken
Open Access

Patient Perspectives on Offers of Buprenorphine in the Emergency Department

Lindsey K Jennings, Kelly Barth, Suzanne Lane, Alyssa Rafferty, Carrie Papa, Louise Haynes, Susan Sonne, Heather McCowin, Phillip Moschella, Alain H Litwin, Jacob J Manteuffel, Kathleen Brady und 1 weitere

JAMA Network Open · 2026

DOI: 10.1001/jamanetworkopen.2026.37671 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2026. Verfasst von Lindsey K Jennings und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Medical University of South Carolina, Charleston. Hauptthemen laut MEDLINE: Buprenorphine, Emergency Service, Hospital, Opioid-Related Disorders, Opiate Substitution Treatment. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Buprenorphine reduces mortality in opioid use disorder (OUD), and emergency department–initiated buprenorphine (EDIB) doubles 30-day treatment retention, yet many patients decline EDIB when offered. Patient-driven factors limiting uptake are not well characterized.

Objective

To identify factors associated with patients accepting or declining EDIB. Design, Setting, and Participants Convergent parallel mixed-methods qualitative study conducted from May 1 to December 31, 2023, with data analyses performed from March 2025 to April 2026, at 4 emergency departments within the National Drug Abuse Treatment Clinical Trials Network (CTN) in South Carolina, Michigan, and Ohio. Adult patients (aged ≥18 years) with OUD who were offered buprenorphine by clinical staff were eligible; prisoners and patients concurrently enrolled in other CTN trials of OUD treatment or overdose prevention were excluded. Main Outcomes and Measures The main outcomes were acceptance or declination of EDIB; validated measures of treatment readiness (Stages of Change Readiness and Treatment Engagement Scale [SOCRATES]), cultural mistrust, perceived discrimination, and social needs; and qualitative interview themes regarding reasons for accepting or declining buprenorphine.

Results

Eighty-two participants completed the study (median [IQR] age, 38 [31-53.5] years; 52 male [64%]). Overall, 19 participants (23%) declined buprenorphine. Among 54 participants who described reasons for accepting EDIB, motivators for accepting EDIB included assistance with opioid withdrawal (37 [69%]), desire to be substance free (21 [39%]), wanting to return to a “normal life” (15 [28%]), fear of overdose or death (13 [24%]), and caring for children (7 [13%]). Among 22 participants who described reasons for declining EDIB, barriers included concern about precipitated withdrawal or adverse effects (11 [50%]), not wanting to be physically dependent on buprenorphine (7 [32%]), and housing and logistical barriers (5 [23%]). SOCRATES treatment readiness (1-5 scale) was similar in patients who accepted (mean [SD] score, 4.11 [0.55]) and declined (mean [SD] score, 4.05 [0.50]) EDIB. Conclusions and Relevance In this mixed-methods qualitative study of adult ED patients with OUD who were offered buprenorphine, declination was driven less by low treatment readiness than by specific, addressable concerns: precipitated withdrawal, physical dependence, and housing and logistical barriers. Targeted interventions addressing these concerns may increase uptake of this life-saving treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BuprenorphineEmergency Service, HospitalOpioid-Related DisordersOpiate Substitution TreatmentNarcotic AntagonistsPatient Acceptance of Health CareHumansMaleAdultFemaleMiddle AgedQualitative ResearchOhioMichigan

Substanzen

BuprenorphineNarcotic Antagonists

Autor:innen und Institutionen

  • Department of Emergency Medicine, Medical University of South Carolina, Charleston.
  • Department of Psychiatry & Behavioral Sciences, Medical University of South Carolina, Charleston.
  • Mercy Health, Youngstown, Ohio.
  • Department of Medicine and Emergency Medicine, Prisma Health, University of South Carolina School of Medicine Greenville, Greenville.
  • Department of Emergency Medicine, Henry Ford Health System, Detroit, Michigan.

Zitieren

APA

Jennings, L. K., Barth, K., Lane, S., Rafferty, A., Papa, C., Haynes, L., Sonne, S., McCowin, H., Moschella, P., Litwin, A. H., Manteuffel, J. J., Brady, K., & Moreland, A. (2026). Patient Perspectives on Offers of Buprenorphine in the Emergency Department. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2026.37671

Vancouver

Jennings LK, Barth K, Lane S, Rafferty A, Papa C, Haynes L, et al. Patient Perspectives on Offers of Buprenorphine in the Emergency Department. JAMA Network Open. 2026. doi:10.1001/jamanetworkopen.2026.37671

BibTeX
@article{Jennings2026,
  author = {Jennings, Lindsey K and Barth, Kelly and Lane, Suzanne and Rafferty, Alyssa and Papa, Carrie and Haynes, Louise and Sonne, Susan and McCowin, Heather and Moschella, Phillip and Litwin, Alain H and Manteuffel, Jacob J and Brady, Kathleen and Moreland, Angela},
  title = {Patient Perspectives on Offers of Buprenorphine in the Emergency Department},
  journal = {JAMA Network Open},
  year = {2026},
  doi = {10.1001/jamanetworkopen.2026.37671}
}
Kostenlos starten →